Kobayashi Competitors

Delisted . USA . 
Stock . Kobayashi Pharmaceutical Co
KBYPFDelisted Stock  USD 32.49  0.00  0.00%   
Kobayashi Pharmaceutical competes with Sun Country, Stepstone, Old Dominion, Procter Gamble, and Royalty Management; as well as few others. The company classifies itself under Consumer Defensive sector and is part of Household & Personal Products industry. Analyzing Kobayashi Pharmaceutical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Kobayashi Pharmaceutical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Kobayashi Pharmaceutical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
32.4932.4932.49
Details
Intrinsic
Valuation
LowRealHigh
27.6227.6235.74
Details
Naive
Forecast
LowNextHigh
32.4932.4932.49
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
32.4932.4932.49
Details

Kobayashi Pharmaceutical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Kobayashi Pharmaceutical and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Kobayashi and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Kobayashi Pharmaceutical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
APAM
+ 0.92
STEP
APAM
+ 0.92
ODFL
GZITF
+ 0.9
ODFL
ODFL
+ 0.85
SNCY
ODFL
+ 0.85
STEP
GZITF
+ 0.84
SNCY
  
High negative correlations   
RMCO
- 0.44
PG
PG
- 0.29
SNCY
PG
- 0.25
STEP
APAM
- 0.12
PG
PG
- 0.11
ODFL
GZITF
- 0.07
PG

Risk-Adjusted Indicators

There is a big difference between Kobayashi Pink Sheet performing well and Kobayashi Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kobayashi Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Kobayashi Pharmaceutical Competitive Analysis

The better you understand Kobayashi Pharmaceutical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Kobayashi Pharmaceutical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Kobayashi Pharmaceutical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
KBYPF SNCY STEP ODFL PG RMCO APAM GZITF
 0.00 
 32.49 
Kobayashi
 0.21 
 14.39 
Sun
 0.23 
 65.89 
Stepstone
 0.46 
 225.14 
Old
 0.06 
 179.26 
Procter
 3.00 
 1.03 
Royalty
 0.33 
 48.79 
Artisan
 0.00 
 0.58 
Yuexiu
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Very steady
Very steady
Very steady
Abnormally volatile
Very steady
Abnormally volatile
Market Performance
(90 Days Performance)
Very Weak
OK
Good
OK
Insignificant
Modest
Good
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
About Average
Low
Very Small
Low
Below Average
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Buy
Buy
Not Available
Hold
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Cautious Hold
Buy
Hold
Hold
Cautious Hold
Buy
Strong Sell
Current Ratio
3.92 X
1.10 X
0.87 X
1.74 X
0.62 X
N/A
1.48 X
0.72 X
Net Asset
252.55 B
1.62 B
3.79 B
5.51 B
122.37 B
13.61 M
1.41 B
35.66 B
Profit Margin
0.12 %
0.04 %
0.05 %
0.21 %
0.17 %
(2.46) %
0.24 %
0.35 %
EBITDA
32.49 B
226.24 M
249.86 M
1.97 B
22.7 B
(1.28 M)
395.31 M
2.94 B
Operating Margin
0.16 %
0.05 %
0.23 %
0.27 %
0.28 %
(0.65) %
0.33 %
0.43 %
Current Valuation
3.94 B
1.29 B
4.86 B
47.83 B
447.19 B
16.91 M
3.44 B
2.81 B
Price To Book
2.85 X
1.38 X
12.08 X
11.46 X
8.27 X
1.24 X
9.19 X
0.61 X
Retained Earnings
N/A
94.23 M
13.77 M
4 B
123.81 B
1.39 M
132.13 M
N/A
Current Asset
N/A
N/A
N/A
381.73 M
33.78 B
N/A
234.61 M
N/A
Five Year Return
N/A
N/A
N/A
0.32 %
2.67 %
N/A
8.10 %
N/A
Beta
0.27
1.49
1.26
0.99
0.41
-0.24
1.79
0.81
Number Of Employees
3.45 K
2.96 K
1.05 K
22.69 K
108 K
N/A
573
2.01 K
Shares Outstanding
76.01 M
52.94 M
72.68 M
213.5 M
2.36 B
14.93 M
70.07 M
1.67 B
Cash Flow From Operations
22.42 B
174.12 M
161.52 M
1.57 B
19.85 B
(1.91 M)
253.03 M
2.57 B
Annual Yield
0.01 %
N/A
0.01 %
0 %
0.02 %
N/A
0.06 %
0.12 %
Total Debt
596 M
697.78 M
268.56 M
200.38 M
33.37 B
2.4 M
312.66 M
13.22 B
Return On Equity
0.0968
0.0842
0.0867
0.3
0.29
-0.17
0.57
0.11
Z Score
5.4
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
0.0633
0.0378
0.0307
0.19
0.11
-0.077
0.14
0.0283
Book Value Per Share
2,653 X
10.44 X
5.47 X
19.53 X
21.68 X
0.67 X
5.31 X
6.71 X
Number Of Shares Shorted
N/A
3.35 M
1.9 M
8.74 M
17.63 M
35.18 K
2.87 M
N/A
Current Liabilities
N/A
N/A
N/A
285.4 M
30.77 B
N/A
629.98 M
N/A
Total Asset
252.55 B
1.62 B
3.79 B
5.51 B
122.37 B
13.61 M
1.41 B
35.66 B
Debt To Equity
0 %
1.30 %
0.08 %
0.03 %
0.74 %
N/A
0.86 %
1.15 %
Last Dividend Paid
84.0
N/A
0.87
0.98
3.89
N/A
2.82
0.42
Short Ratio
N/A
3.39 X
3.26 X
5.48 X
2.67 X
4.34 X
6.28 X
N/A
Target Price
N/A
19.13
71.36
197.82
180.46
N/A
44.63
N/A
Shares Owned By Institutions
21.77 %
95.40 %
93.84 %
80.40 %
69.11 %
1.25 %
91.02 %
16.62 %
Market Capitalization
5.37 B
763.39 M
7.82 B
48.07 B
422.16 B
14.93 M
3.42 B
982.59 M
Price To Earning
34.29 X
15.79 X
5.11 X
46.55 X
25.21 X
N/A
8.34 X
7.22 X
Price To Earnings To Growth
N/A
0.61 X
2.35 X
3.35 X
3.79 X
N/A
1.38 X
N/A
Price To Sales
0.03 X
0.72 X
9.77 X
8.11 X
5.03 X
23.18 X
3.21 X
0.28 X
Net Income
19.71 B
72.18 M
58.09 M
1.24 B
14.88 B
(2.07 M)
311.8 M
1.46 B
Earnings Per Share
1.94 X
0.83 X
0.61 X
5.71 X
5.79 X
(0.09) X
3.60 X
0.11 X
Shares Owned By Insiders
34.50 %
4.60 %
17.82 %
10.12 %
0.05 %
50.42 %
2.58 %
44.24 %
Revenue
155.25 B
1.05 B
711.63 M
5.87 B
84.04 B
361.62 K
975.13 M
3.7 B
Working Capital
N/A
(147.23 M)
(32.15 M)
598.67 M
(8.92 B)
(1.08 M)
(119.87 M)
N/A
Cash And Equivalents
116.15 B
289.58 M
106.35 M
375.56 M
8.25 B
N/A
163.29 M
2.92 B
Cash Per Share
N/A
4.98 X
1.73 X
3.37 X
2.83 X
N/A
2.42 X
1.74 X
Gross Profit
88.77 B
245.38 M
562.83 M
2.49 B
39.25 B
N/A
483.3 M
2.25 B
Day Typical Price
32.49
14.45
65.97
225.39
179.06
1.01
48.77
0.58
Accumulation Distribution
N/A
5426.91
5154.03
8398.52
28736.88
101.36
3369.63
N/A
Daily Balance Of Power
0.0
(0.09)
(0.19)
0.3456
(0.07)
0.6
0.2254
0.0
Period Momentum Indicator
N/A
(0.03)
(0.15)
1.03
(0.10)
0.03
0.16
N/A
Rate Of Daily Change
1.0
1.0
1.0
1.0
1.0
1.03
1.0
1.0
Day Median Price
32.49
14.48
66.01
225.51
178.96
1.0
48.76
0.58
Price Action Indicator
N/A
(0.10)
(0.20)
0.14
0.25
0.04
0.11
N/A
Relative Strength Index
N/A
70.22
73.65
71.95
52.38
62.91
66.12
100.0
Coefficient Of Variation
(812.40)
669.94
617.06
912.91
941.2
1167.18
629.85
763.13
Mean Deviation
0.4937
2.62
1.47
1.55
0.7206
3.64
1.31
0.8351
Jensen Alpha
(0.35)
0.3512
0.119
(0.01)
0.1035
0.4082
0.0543
0.4676
Total Risk Alpha
(0.60)
(0.07)
(0.02)
(0.14)
(0.07)
(0.41)
(0.02)
(0.13)
Sortino Ratio
N/A
0.1305
0.1165
0.0497
(0.04)
0.0743
0.081
N/A
Downside Variance
N/A
8.6
3.25
5.29
0.8916
15.05
3.48
N/A
Standard Deviation
2.04
3.49
2.14
2.3
0.9626
4.97
1.82
3.29
Kurtosis
66.0
0.6445
7.71
7.61
0.9909
4.83
3.43
65.4
Potential Upside
N/A
7.47
2.82
2.68
1.74
8.42
2.52
N/A
Treynor Ratio
(0.36)
0.4092
0.1971
0.1235
(1.05)
6.89
0.1585
(1.14)
Maximum Drawdown
16.54
16.71
16.32
14.71
4.66
31.36
12.25
26.67
Variance
4.15
12.15
4.6
5.29
0.9266
24.71
3.3
10.8
Market Risk Adjusted Performance
(0.35)
0.4192
0.2071
0.1335
(1.04)
6.9
0.1685
(1.13)
Risk Adjusted Performance
(0.09)
0.1219
0.1303
0.0904
0.0833
0.074
0.1272
0.1078
Skewness
(8.12)
0.5006
1.33
1.06
(0.13)
1.44
0.5354
8.07
Semi Deviation
N/A
2.62
1.58
2.11
0.771
3.35
1.67
N/A
Information Ratio
(0.19)
0.1098
0.0979
0.0497
(0.04)
0.058
0.0831
0.0892
Value At Risk
N/A
(4.50)
(2.12)
(3.52)
(1.26)
(6.42)
(2.47)
N/A
Expected Short fall
N/A
(3.11)
(1.67)
(1.56)
(0.77)
(5.23)
(1.37)
N/A
Downside Deviation
N/A
2.93
1.8
2.3
0.9443
3.88
1.86
N/A
Semi Variance
N/A
6.84
2.48
4.46
0.5944
11.23
2.78
N/A

Kobayashi Pharmaceutical Competition Performance Charts

Five steps to successful analysis of Kobayashi Pharmaceutical Competition

Kobayashi Pharmaceutical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Kobayashi Pharmaceutical in relation to its competition. Kobayashi Pharmaceutical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Kobayashi Pharmaceutical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Kobayashi Pharmaceutical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Kobayashi Pharmaceutical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Kobayashi Pharmaceutical position

In addition to having Kobayashi Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Funds Thematic Idea Now

Small Growth Funds
Small Growth Funds Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Kobayashi Pink Sheet

If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY